Nitric Oxide Production by Myeloid Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function. (Q48525603)

12 February 2018

title

Nitric Oxide Production by Myeloid Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function. (English)

1 reference

12 February 2018

22

John C Byrd

1 reference

12 February 2018

23

Michael A Caligiuri

1 reference

12 February 2018

Susheela Tridandapani

21

Susheela Tridandapani

1 reference

12 February 2018

Natarajan Muthusamy

20

Natarajan Muthusamy

1 reference

12 February 2018

Elizabeth L McMichael

4

Elizabeth L McMichael

1 reference

12 February 2018

Bethany L Mundy-Bosse

3

Bethany L Mundy-Bosse

1 reference

12 February 2018

Andrew Stiff

1

Andrew Stiff

1 reference

12 February 2018

Prashant Trikha

2

Prashant Trikha

1 reference

12 February 2018

Robert Wesolowski

14

Robert Wesolowski

1 reference

12 February 2018

Kari Kendra

7

Kari Kendra

1 reference

12 February 2018

Vincent M Hsu

12

Vincent Hsu

1 reference

12 February 2018

Megan C Duggan

13

Megan C Duggan

1 reference

12 February 2018

Ian Landi

11

Ian Landi

1 reference

12 February 2018

Thomas A Mace

5

Thomas A Mace

1 reference

12 February 2018

Shalini Gautam

9

Shalini Gautam

1 reference

12 February 2018

David Abood

10

David Abood

1 reference

12 February 2018

author name string

Brooke Benner

6

1 reference

12 February 2018

Amanda Campbell

8

1 reference

12 February 2018

Matthew Old

15

1 reference

12 February 2018

John H Howard

16

1 reference

12 February 2018

Lianbo Yu

17

1 reference

12 February 2018

Nancy Stasik

18

1 reference

12 February 2018

Thomas Olencki

19

1 reference

12 February 2018

William E Carson

24

1 reference

12 February 2018

language of work or name

English

0 references

publication date

23 January 2018

1 reference

12 February 2018

published in

Clinical Cancer Research

1 reference

12 February 2018

The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma

cites work

1 reference

12 December 2020

Interleukin-2-activated rat natural killer cells express inducible nitric oxide synthase that contributes to cytotoxic function and interferon-gamma production

1 reference

12 December 2020

Human NK cells express endothelial nitric oxide synthase, and nitric oxide protects them from activation-induced cell death by regulating expression of TNF-alpha

1 reference

12 December 2020

Prognostic value of intratumoral natural killer cells in gastric carcinoma

1 reference

12 December 2020

A view to a kill: signals triggering cytotoxicity

1 reference

12 December 2020

Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia

1 reference

12 December 2020

IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells

1 reference

12 December 2020

Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression

1 reference

12 December 2020

Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells

1 reference

12 December 2020

Interleukin-21 enhances NK cell activation in response to antibody-coated targets

1 reference

12 December 2020

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses

1 reference

12 December 2020

Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

1 reference

12 December 2020

The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines

1 reference

12 December 2020

Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma

1 reference

12 December 2020

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

1 reference

12 December 2020

Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.

1 reference

12 December 2020

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

12 December 2020

Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.

1 reference

12 December 2020

Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes

1 reference

12 December 2020

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity

1 reference

12 December 2020

IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function.

1 reference

12 December 2020

Delivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor response

1 reference

12 December 2020

Innate or adaptive immunity? The example of natural killer cells

1 reference

12 December 2020

IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production

1 reference

12 December 2020

A flow-cytometry assisted segregation of responding and non-responding population of endothelial cells for enhanced detection of intracellular nitric oxide production

1 reference

12 December 2020

Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4⁺ T cells from patients with GI malignancy

1 reference

12 December 2020

Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.

1 reference

12 December 2020

Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

1 reference

12 December 2020

Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells.

1 reference

12 December 2020

Antibody therapy of cancer

1 reference

12 December 2020

Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release

1 reference

12 December 2020

The key role of IL-6-arginase cascade for inducing dendritic cell-dependent CD4(+) T cell dysfunction in tumor-bearing mice

1 reference

12 December 2020

NK cell-based immunotherapy for malignant diseases

1 reference

12 December 2020

Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells

1 reference

12 December 2020

Tumor microenvironmental conversion of natural killer cells into myeloid-derived suppressor cells.

1 reference

12 December 2020

A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model

1 reference

12 December 2020

Myeloid-derived suppressor cells confer tumor-suppressive functions on natural killer cells via polyinosinic:polycytidylic acid treatment in mouse tumor models.

1 reference

12 December 2020

Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways

1 reference

12 December 2020

The critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity.

1 reference

12 December 2020

Melanoma NOS1 expression promotes dysfunctional IFN signaling

1 reference

12 December 2020

Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy.

1 reference

12 December 2020

CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs.

1 reference

12 December 2020

Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity

1 reference

12 December 2020

Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment

1 reference

12 December 2020

Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancer.

1 reference

12 December 2020

The tyrosine kinase inhibitors imatinib and dasatinib reduce myeloid suppressor cells and release effector lymphocyte responses

1 reference

12 December 2020

Myeloid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization

1 reference

12 December 2020

IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age.

1 reference

12 December 2020

Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy

1 reference

12 December 2020

Brain function in iNOS knock out or iNOS inhibited (l-NIL) mice under endotoxic shock.

1 reference

12 December 2020

Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells

1 reference

12 December 2020

Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1.

1 reference

12 December 2020

Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment

1 reference

12 December 2020

IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells

1 reference

12 December 2020

Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells

1 reference

12 December 2020

10.1158/1078-0432.CCR-17-0691

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

29363526

1 reference

12 February 2018